Baldwin Insurance Group (BWIN) Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025 summary
Event summary combining transcript, slides, and related documents.
Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025 summary
23 Dec, 2025Business performance and growth
Achieved 10x revenue growth and 11x EBITDA growth over five years, scaling from $138M to $1.4B in revenue and $28M to $312M in EBITDA.
Expanded headcount from 500 to over 4,000, transforming from a regional to a national presence.
MGA business grew from one product and $60M premium to nearly 20 products and $1.1B premium, supported by proprietary technology.
Embedded personal insurance business now leads with 72% market share among top 25 home builders.
Completed 35 acquisitions in the first three years as a public company.
Financial momentum and margin trends
Achieved 200 basis points of margin accretion in 2024, with underlying improvements masked by outside commission expense.
Compensation and benefits ratio improved by 490 basis points; OpEx leverage improved by 150 basis points.
Margin accretion expected to accelerate as new MGA products mature and outside commission expense normalizes.
Five-year plan targets $3B revenue and 30% margin, with annual margin accretion but not in a linear fashion.
Margin headwinds in 2024 include $25M from QBE replatforming and reinsurance cost increases.
Organic growth drivers and business unit performance
IS business achieved 21.5% sales velocity, far exceeding industry median of 11.5%.
UCTS business leverages data to build proprietary products, achieving 32% premium growth and sub-55% loss ratios.
Main Street business holds exclusive partnerships with over 70% of top 25 home builders, winning six new top 50 builders last year.
Despite $35M in headwinds, guidance remains for double-digit organic growth.
Latest events from Baldwin Insurance Group
- Organic growth, tech investment, and successful M&A drive outperformance and future momentum.BWIN
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - 2025 saw robust growth and margin gains; 2026 targets acceleration with AI and $250M buyback.BWIN
Q4 202527 Feb 2026 - Q2 revenue up 14%, organic growth 19%, adjusted EBITDA up 22%, and free cash flow up 38%.BWIN
Q2 20242 Feb 2026 - Approaching a financial inflection point with accelerating growth, margin expansion, and free cash flow.BWIN
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 2024 saw 11% revenue growth, 14% organic gains, and improved margins and liquidity.BWIN
Q3 202417 Jan 2026 - Organic revenue up 19% in Q4, margins and free cash flow surged, outlook remains strong.BWIN
Q4 202429 Dec 2025 - $1.026B merger forms the largest colleague-owned U.S. broker, targeting $60M synergies by 2028.BWIN
M&A Announcement3 Dec 2025 - Record growth, performance-based pay, and strong governance highlighted; all proposals recommended for approval.BWIN
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay approval, and auditor ratification.BWIN
Proxy Filing1 Dec 2025